Form4insider filings, from the source

SEC Form 4 · accession 0001628280-26-058939

Ginkgo Bioworks Holdings, Inc. · DNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Steven P. Coen
Officer — See remarks
Period of report
Aug 21, 2026
Accepted (ET)
Aug 25, 2026 · 5:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001830214

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockF1Aug 21, 2026M587—A52,025D
Class A Common StockF1Aug 21, 2026M156—A52,181D
Class A Common StockAug 24, 2026S330$6.977D51,851D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F3—Aug 21, 2026M587D——Class A Common Stock5875,296D
Restricted Stock UnitsF1,F4—Aug 21, 2026M156D——Class A Common Stock1562,975D

Explanation of responses

Remarks

Chief Financial Officer